GlassScriptPhysician profile
Emily K Chan
NPI 1700545050
$2,463.53
in general payments reported to CMS, 2019-2025
20 companies · $89.19 in 2025
The $89.19 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $445 · 2023: $1,394 · 2024: $535 · 2025: $89.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,018.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,018.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $374.42 | 2023-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Amgen INC. | $305.00 | 2022-2024 | Otezla, Repatha |
| Redhill Biopharma INC. | $247.09 | 2022-2024 | Talicia, Aemcolo, Movantik |
| Bayer Healthcare Pharmaceuticals INC. | $228.15 | 2023-2024 | |
| Ibsa Pharma INC. | $213.19 | 2023-2024 | Licart, Tirosint, Licart |
| Boehringer Ingelheim Pharmaceuticals, INC. | $158.08 | 2022-2023 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $124.98 | 2023 | Farxiga |
| Ironwood Pharmaceuticals, INC | $122.58 | 2024 | |
| Gilead Sciences, INC. | $120.99 | 2023 | Vemlidy |
| Abbvie INC. | $103.77 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $95.16 | 2022-2025 | Gardasil 9, Vaxneuvance, Rotateq |
| Kowa Pharmaceuticals America, INC. | $81.78 | 2022-2023 | Livalo, Seglentis |
| Nestle Healthcare Nutrition INC. | $63.22 | 2023 | |
| Dexcom, INC. | $51.67 | 2022 | |
| Lilly USA, LLC | $45.20 | 2023-2024 | Jardiance, Zepbound |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $40.27 | 2023-2024 | Rybelsus, Ozempic |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $38.54 | 2023 | Xifaxan, Trulance |
| Xeris Pharmaceuticals, INC. | $18.40 | 2023 | Gvoke Hypopen |
| Kci USA, INC. | $15.80 | 2022 | |
| Exact Sciences Corporation | $15.24 | 2023 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Chan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.